Skip to main content

Advertisement

Log in

The Effects of Vasoactive Intestinal Peptide on Dura Mater Nitric Oxide Levels and Vessel-Contraction Responses in Sympathectomized Rats

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

Nitric oxide (NO) and neurogenic inflammation in dura mater due to nociceptor activation has been implicated for pathophysiology of primary headache disorders. Development of migraine has also been observed in patients treated with ganglion blockage for sympathetic reflex dystrophy. Vasoactive intestinal peptide (VIP) is an antioxidant, anti-inflammatory, and neuroprotective neuropeptide. This study is intended to investigate the effects of VIP on dura mater NO levels and vessel-contraction responses in sympathectomized rats. In the experiments, 30 male rats in five groups were used. Group 1 sympathectomized: under anesthesia, superior cervical sympathetic ganglion was removed via incision at the center line in the neck area. Group 2 sympathectomized + VIP: postoperative VIP of 25 ng/kg/day (0.2 ml) intraperitoneally administered to the rats exposed to the same operations for 5 days. Group 3 sham: ganglia and nerves were exposed but not dissected. Group 4 control: no treatment was done. Group 5 VIP: only VIP was administered for 5 days. Sympathectomy induced a significant increase in dura mater NO levels and VIP decreased NO to control levels and increased the norepinephrine vessel-contraction responses of sympathectomized rats. VIP is an efficient NO modulator in superior cervical ganglionectomized rats.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

Abbreviations

cGMP:

Cyclic guanosine monophosphate

CGRP:

Calcitonin gene-related peptide

CNS:

Central nervous system

COX-2:

Cyclooxygenase-2

GTN:

Glyceryl trinitrate

IS:

Internal standard

KH:

Krebs–Henseleit

MMP-9:

Matrix metalloproteinase-9

NE:

Norepinephrine

NO:

Nitric oxide

SCG:

Superior cervical ganglionectomized group

SNS:

Sympathetic nervous system

TNF-alpha:

Tumor necrosis factor-alpha

PACAP:

Pituitary adenylate cyclase-activating polypeptide

VIP:

Vasoactive intestinal peptide

References

  • Arranz A, Gutiérrez-Cañas I, Carrión M et al (2008a) VIP reverses the expression profiling of TLR4-stimulated signaling pathway in rheumatoid arthritis synovial fibroblasts. Mol Immunol 45:3065–3073

    Article  CAS  PubMed  Google Scholar 

  • Arranz A, Abad C, Juarranz Y, Leceta J, Martinez C, Gomariz RP (2008b) Vasoactive intestinal peptide as a healing mediator in Crohn's disease. Neuroimmunomodulation 15:46–53

    CAS  PubMed  Google Scholar 

  • Beleña J, Petersen I, Cabeza R, Núñez M, Vidal A (2006) Migraine headache: a rare complication after cervicothoracic block. J Headaches Pain 7:367–368

    Article  Google Scholar 

  • Bergerot A, Reynier-Rebuffel AM, Callebert J, Aubineau P (2000) Long-term superior cervical sympathectomy induces mast cell hyperplasia and increases histamine and serotonin content in the rat dura mater. Neuroscience 96:205–213

    Article  CAS  PubMed  Google Scholar 

  • Bolden DA (1996) Sympathectomy induces c-Jun in adult trigeminal neurons: an immunohistochemical and tract-tracing study. Neurosci Lett 214:83–86

    Article  CAS  PubMed  Google Scholar 

  • Bolden DA, Sternini C, Kruger L (1997) GAP-43 mRNA and calcitonin gene-related peptide mRNA expression in sensory neurons are increased following sympathectomy. Brain Res Bull 42:39–50

    Article  CAS  PubMed  Google Scholar 

  • Can C, Töre F, Tunçel N, Uysal O, Gürer F, Ak D et al (2004) Protective effect of vasoactive intestinal peptide on testicular torsion–detorsion injury: association with heparin-containing mast cells. Urology 63:195–200

    Article  PubMed  Google Scholar 

  • Dogrukol-Ak D, Tore F, Tuncel N (2004) Passage of VIP/PACAP/secretin family across the blood–brain barrier: therapeutic effects. Curr Pharm Des 10:1325–1340

    Article  CAS  PubMed  Google Scholar 

  • Erden SH, Tunçel N, Aydin Y, Sahintürk V, Koşar M, Tunçel M (1998) The effect of vasoactive intestinal peptide (VIP) and inhibition of nitric oxide on renal tissue injury of rats exposed to hemorrhagic ischemia and retransfusion: a possible interaction mechanism among mast cells and tissue histamine. Ann N Y Acad Sci 865:570–581

    Article  CAS  PubMed  Google Scholar 

  • Giladi E, Hill JM, Dresner E, Stack CM, Gozes I (2007) Vasoactive intestinal peptide (VIP) regulates activity-dependent neuroprotective protein (ADNP) expression in vivo. J Mol Neurosci 33:278–283

    Article  CAS  PubMed  Google Scholar 

  • Gozes I, Furman S (2004) Clinical endocrinology and metabolism. Potential clinical applications of vasoactive intestinal peptide: a selected update. Best Pract Res Clin Endocrinol Metab 18:623–640

    Article  CAS  PubMed  Google Scholar 

  • Hansen J, Sitarz J, Birk S et al (2006) Vasoactive intestinal polypeptide evokes only a minimal headache in healthy volunteers. Cephalalgia 26:992–1003

    Article  CAS  PubMed  Google Scholar 

  • Keller JT, Marfurt CF, Dimlich RV, Tierney BE (1989) Sympathetic innervation of the supratentorial dura mater of the rat. J Comp Neurol 290:310–321

    Article  CAS  PubMed  Google Scholar 

  • Kim GM, Jin KS, Chung CS (2008) Differential effects of corticosteroids on the expression of cyclooxygenase-2, tumour necrosis factor-alpha and matrix metalloproteinase-9 in an animal model of migraine. Cephalalgia 28:1179–1187

    Article  PubMed  Google Scholar 

  • Kruuse C, Iversen HK, Jansen-Olesen I, Edvinsson L, Olesen J (2009) Calcitonin gene-related peptide (CGRP) levels during glyceryl trinitrate (GTN)-induced headache in healthy volunteers. Cephalalgia. doi:10.1111/j.1468-2982.2009.01963.x

  • Li J, Vause CV, Durham PL (2008) Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res 1196:22–32

    Article  CAS  PubMed  Google Scholar 

  • Neeb L, Reuter U (2007) Nitric oxide in migraine. CNS Neurol Disord Drug Targets 6:258–264

    Article  CAS  PubMed  Google Scholar 

  • Offenhauser N, Zinck T, Hoffmann J et al (2005) CGRP release and c-fos expression within trigeminal nucleus caudalis of the rat following glyceryltrinitrate infusion. Cephalalgia 25:225–236

    Article  CAS  PubMed  Google Scholar 

  • Olesen J (2008) The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol Ther 120:157–171

    Article  CAS  PubMed  Google Scholar 

  • Peroutka SJ (2004) Migraine: a chronic sympathetic nervous system disorder. Headache 44:53–64

    Article  PubMed  Google Scholar 

  • Peroutka SJ (2005) Neurogenic inflammation and migraine: implications for the therapeutics. Mol Interv 5:304–311

    Article  CAS  PubMed  Google Scholar 

  • Pincus DW, DiCicco-Bloom EM, Black IB (1990) Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts. Nature 343:564–567

    Article  CAS  PubMed  Google Scholar 

  • Rahmann A, Wienecke T, Hansen JM, Fahrenkrug J, Olesen J, Ashina M (2008) Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia 28:226–236

    Article  CAS  PubMed  Google Scholar 

  • Said SI (1996) Vasoactive intestinal peptide and nitric oxide: divergent roles in relation to tissue injury. Ann N Y Acad Sci 805:379–387

    Article  CAS  PubMed  Google Scholar 

  • Said SI, Dickman KG (2000) Pathways of inflammation and cell death in the lung: modulation by vasoactive intestinal peptide. Regul Pept 93:21–29

    Article  CAS  PubMed  Google Scholar 

  • Said SI, Berisha HI, Pakbaz H (1995) N-methyl-D-aspartate receptors outside the central nervous system: activation causes acute lung injury that is mediated by nitric oxide synthesis and prevented by vasoactive intestinal peptide. Neuroscience 65:943–946

    Article  CAS  PubMed  Google Scholar 

  • Sanchez del Rio M, Reuter U, Moskowitz MA (2000) Central and peripheral mechanisms of migraine. Funct Neurol 15:157–162

    PubMed  Google Scholar 

  • Schytz HW, Birk S, Wienecke T, Kruuse C, Olesen J, Ashina M (2009) PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain 132:16–25

    Article  PubMed  Google Scholar 

  • Spierings ELH (2003) Headache following cervical sympathectomy and results of a blood flow study in the cat. Headache 43:410–414

    Article  PubMed  Google Scholar 

  • Szema AM, Hamidi SA, Lyubsky S et al (2006) Mice lacking the VIP gene show airway hyperresponsiveness and airway inflammation, partially reversible by VIP. Am J Physiol Lung Cell Mol Physiol 291:L880–L886

    Article  CAS  PubMed  Google Scholar 

  • Tikiz H, Tunçel N, Akin MZ, Gürer F (1992) The effect of vasoactive intestinal peptide (VIP) and naloxone combination on survival rates in rats exposed to severe hemorrhage. Peptides 13:83–89

    Article  CAS  PubMed  Google Scholar 

  • Tore F, Reynier-Rebuffel AM, Tuncel N, Callebert J, Aubineau P (2001) Effects of sepsis on mast cells in rat dura mater: influence of L-NAME and VIP. Br J Pharmacol 134:1367–1374

    Article  CAS  PubMed  Google Scholar 

  • Tunçel N, Töre FC (1998) The effect of vasoactive intestinal peptide (VIP) and inhibition of nitric oxide synthase on survival rate in rats exposed to endotoxin shock. Ann N Y Acad Sci 865:586–589

    Article  PubMed  Google Scholar 

  • Tunçel N, Töre F, Sahintürk V, Ak D, Tunçel M (2000) Vasoactive intestinal peptide inhibits degranulation and changes granular content of mast cells: a potential therapeutic strategy in controlling septic shock. Peptides 21:81–89

    Article  PubMed  Google Scholar 

  • Tunçel M, Dogrukol-Ak D, Erkasap N (2001) Modified method for the determination of capillary electrophoresis nitric oxide-correlated nitrate in tissue homogenates. J Chromatogr B Biomed Sci Appl 751:257–263

    Article  PubMed  Google Scholar 

  • Tunçel N, Sener E, Cerit C, Karasu U, Gürer F, Sahintürk V et al (2005) Brain mast cells and therapeutic potential of vasoactive intestinal peptide in a Parkinson's disease model in rats: brain microdialysis, behavior, and microscopy. Peptides 26:827–836

    Article  PubMed  CAS  Google Scholar 

  • Yildiz SK, Yildiz N, Korkmaz B, Altunrende B, Gezici AR, Alkoy S (2008) Sympathetic skin responses from frontal region in migraine headache: a pilot study. Cephalalgia 28:696–704

    Article  CAS  PubMed  Google Scholar 

  • Zinck T, Illum R, Jansen-Olesen I (2006) Increased expression of endothelial and neuronal nitric oxide synthase in dura and pia mater after air stress. Cephalalgia 26:14–25

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was presented in Neuropeptide Festival, Joint Meeting of the European Neuropeptide Club and the Summer Neuropeptide Conference, Salzburg, Austria, 20–23 July 2009.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fatma Tore.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tore, F., Korkmaz, O.T., Dogrukol-Ak, D. et al. The Effects of Vasoactive Intestinal Peptide on Dura Mater Nitric Oxide Levels and Vessel-Contraction Responses in Sympathectomized Rats. J Mol Neurosci 41, 288–293 (2010). https://doi.org/10.1007/s12031-009-9310-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12031-009-9310-8

Keywords

Navigation